Skip to main content
. 2011 Dec 29;2012:961232. doi: 10.1155/2012/961232

Table 1.

Risk of ovarian toxicity of antineoplastic drugs.

High risk Cyclophosphamide, ifosfamide, busulfan, mechlorethamine, melphalan
Intermediate risk Doxorubicin, epirubicin, cisplatin, docetaxel, paclitaxel

Low risk Vincristine, methotrexate, 5-fluorouracil, trastuzumab